Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Philips NV
  6. News
  7. Summary
    PHIA   NL0000009538

PHILIPS NV

(PHIA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Philips : Periodic update on transaction details related to Philips' share repurchases

11/26/2021 | 05:10am EST
Nov 26, 2021
Periodic update on transaction details related to Philips' share repurchases
Amsterdam, the Netherlands - Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from November 19, 2021 up to and including November 24, 2021 a total of 4,011,088 of its own common shares were repurchased, with a weighted average purchase price of EUR 35.26. These repurchases were made under the repurchase program for capital reduction purposes, which was announced on July 26, 2021. Since the start of the program, Philips also entered into a number of forward transactions, with settlement dates in 2022, 2023 and 2024. Further details can be found via this link.
About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Click here to read moreClick here to read less

Disclaimer

Royal Philips NV published this content on 26 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 November 2021 10:09:04 UTC.


ę Publicnow 2021
All news about PHILIPS NV
09:00aPhilips supports the American Heart Association's efforts to raise awareness of cardiov..
AQ
01/18Philips to Collaborate With Cydar on Image-Guided Endovascular Surgery
MT
01/18Royal Philips Signs Strategic Partnership With Cydar
MT
01/18Philips integrates cloud-based AI and 3D mapping into its Mobile C-arm System Series &n..
AQ
01/18Philips Integrates Cloud-Based AI and 3D Mapping into Mobile C-Arm System Series –..
CI
01/14HSBC Upgrades Koninklijke Philips to Buy from Hold, Lowers Price Target to 38 Euros Fro..
MT
01/14PHILIPS NV : Barclays reiterates its Buy rating
MD
01/14PHILIPS NV : Goldman Sachs reiterates its Buy rating
MD
01/14PHILIPS : Periodic update on transaction details related to Philips' share repurchases
PU
01/13ResMed Receives Price Target Boost to $234 From $227 From RBC on 'Positive Implications..
MT
More news
Analyst Recommendations on PHILIPS NV
More recommendations
Financials
Sales 2021 17 361 M 19 706 M 19 706 M
Net income 2021 3 429 M 3 892 M 3 892 M
Net Debt 2021 4 250 M 4 824 M 4 824 M
P/E ratio 2021 7,47x
Yield 2021 2,96%
Capitalization 25 690 M 29 157 M 29 161 M
EV / Sales 2021 1,72x
EV / Sales 2022 1,62x
Nbr of Employees 77 084
Free-Float 95,8%
Chart PHILIPS NV
Duration : Period :
Philips NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHILIPS NV
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 30,01 €
Average target price 42,41 €
Spread / Average Target 41,3%
EPS Revisions
Managers and Directors
Frans van Houten Chief Executive Officer
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Feike Sijbesma Chairman-Supervisory Board
Jan Kimpen Chief Medical Officer
Sophie Bechu Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PHILIPS NV-8.42%28 756
THERMO FISHER SCIENTIFIC-11.56%232 528
DANAHER CORPORATION-12.76%206 084
INTUITIVE SURGICAL, INC.-18.32%105 560
SIEMENS HEALTHINEERS AG-9.69%74 685
EDWARDS LIFESCIENCES CORPORATION-10.34%72 317